Research

Our vision is to understand the causes of Scleroderma & Raynaud's using this knowledge to develop better diagnostics and treatments which will drive improvements in the quality of life of people with these conditions.  We will achieve this through funding high quality research which will have the biggest impact for our community. 

The benefits of medical research are far-reaching and ultimately it helps everyone; from the thousands of people and families in the UK who are affected by scleroderma and Raynaud's, to the health professionals who are involved in the management of these complex conditions.

SRUK was founded in 2016 and we are proud of the legacy of our two founding charities: the Raynaud's and Scleroderma Association (RSA) and the Scleroderma Society. Our Impact Report celebrates the impact of over 3 decades of research. Your support has funded over 100 research grants, and over £10 million in cutting edge science aligning to the 4 priority areas identified by our community and clinical experts; precision medicine, early detection and diagnosis, quality of life, and causes, as established in our research strategy.  You can read about the advances that have been made at all levels, from building our knowledge about the very basic mechanisms underlying the conditions, through to pioneering new methods of earlier detection and diagnosis. This has set us up for the future and we are now in the incredible position of being able to accelerate research even further than it has been before. This is all due to the ground breaking work that has been carried out through our communities working together. 

Get involved in research

Could you be a part of the next phase of scientific research into scleroderma or Raynaud's? Please follow the links below to find out more, including all the latest research news as well as the various ways you could get involved in an upcoming project. If you would like any more information, please get in touch with us, as we will be very happy to help.

To find out more about the pioneering research projects that your money is helping to support, visit the pages below. 

The Raynaud’s and Scleroderma Association (RSA) and the Scleroderma Society (SS) merged in 2016 to become SRUK, having being founded separately in 1982. Both had a rich history of providing excellent support services to the community and investing in research to improve the knowledge and understanding of these conditions. Between them, they funded over £10 million in research – leading to many breakthroughs which are highlighted in our Impact Report.

SRUK’s research policy is guided by both our Research Strategy, and the Association of Medical Research Charities (AMRC) of which we are a proud member.  

Our statement on the use of animals in research.